[go: up one dir, main page]

Khan et al., 2019 - Google Patents

Comparison of drug eluting versus bare metal stents for pulmonary vein stenosis in childhood

Khan et al., 2019

Document ID
294875245520907424
Author
Khan A
Qureshi A
Justino H
Publication year
Publication venue
Catheterization and Cardiovascular Interventions

External Links

Snippet

Objective Comparison of outcomes using bare metal (BMS) and drug‐eluting (DES) stents in pulmonary vein stenosis (PVS). Background PVS is a serious condition with frequent restenosis after surgical and percutaneous interventions. After experiencing encouraging …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes

Similar Documents

Publication Publication Date Title
Khan et al. Comparison of drug eluting versus bare metal stents for pulmonary vein stenosis in childhood
Holzer et al. Stenting of aortic coarctation: acute, intermediate, and long‐term results of a prospective multi‐institutional registry—Congenital Cardiovascular Interventional Study Consortium (CCISC)
Martin et al. Percutaneous transcatheter pulmonary valve replacement in children weighing less than 20 kg
Barbeau Radial loop and extreme vessel tortuosity in the transradial approach: Advantage of hydrophilic‐coated guidewires and catheters
Bruckheimer et al. Covered Cheatham‐Platinum stents for serial dilation of severe native aortic coarctation
Saeed et al. Percutaneous coronary intervention in tortuous coronary arteries: associated complications and strategies to improve success
Bruckheimer et al. Coarctation of the aorta treated with the Advanta V12 large diameter stent: acute results
McLennan et al. Pulmonary vein stenosis: moving from past pessimism to future optimism
Mwipatayi et al. First-in-man experience of self-expanding nitinol stents combined with drug-coated balloon in the treatment of femoropopliteal occlusive disease
Hall et al. Saphenous vein graft failure: seeing the bigger picture
Vaughn et al. Transcatheter stenting of the systemic‐to‐pulmonary artery shunt: A 7‐year experience from a single tertiary center
Weber et al. Endovascular stenting for native coarctation of the aorta is an effective alternative to surgical intervention in older children
Habara et al. The first clinical experience with a novel directional coronary atherectomy catheter: preliminary Japanese multicenter experience
Bosiers et al. Two-year outcome after Xpert stent implantation for treating below the knee lesions in critical limb ischemia
Vallurupalli et al. Optimization of stent implantation using a high pressure inflation protocol
Shah et al. Anchor balloon, buddy wire, and wire and sheath techniques to deploy percutaneous pulmonary valves in tetralogy of fallot patients
Frerker et al. Ipsilateral arterial access for management of vascular complication in transcatheter aortic valve implantation
Morton et al. Simultaneous kissing stent technique to treat left main stem bifurcation disease
De Giovanni Timing, frequency, and results of catheter intervention following recruitment of major aortopulmonary collaterals in patients with pulmonary atresia and ventricular septal defect
Garriboli et al. PTA and stenting of femoropopliteal trunk with cordis Smartflex stent system: a single-center experience
Kasar et al. Balloon-expandable stents for native coarctation of the aorta in children and adolescents
Sevil et al. Management of endovascular treatment in spontaneous iliac artery dissections: Applications enabling classical surgery
Shah et al. Clinical outcomes using aggressive approach to anatomic screening and endovascular revascularization in a veterans affairs population with critical limb ischemia
Ahmed et al. Acute limb ischemia caused by dissection following percutaneous coronary intervention using right radial approach
Brodmann et al. Optimized drug‐coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the Tack Endovascular System: Tack Optimized Balloon Angioplasty (TOBA) III 24‐month results in standard and long lesions